Virtual Pediatric Hospital: ElectricAirway: Upper Airway Problems in Children: Discussion of Influenza Virus
ElectricAirway: Upper Airway Problems in Children
Discussion of Influenza Virus
Donna M. Santer, M.D., Michael P. D'Alessandro, M.D.
Peer Review Status: Externally Peer Reviewed by Lauren D Holinger, MD, Robert J. Winter, MD and the AMA
Influenza viruses are RNA-containing orthomyxoviruses that have three
antigenic types designated A-C. Epidemics are caused by types A and B.
Influenza is spread by droplet transmission with the highest attack rate being in school-age children with secondary spread to household contacts. It is highly contagious with an incubation period of 1-3 days. Patients can shed the virus for 7 days afterwards. Complications include bronchitis, pneumonia, Reye's syndrome, myositis, and central nervous system manifestations. Patients at risk are neonates and those with sickle cell anemia, bronchopulmonary dysplasia, asthma, cystic fibrosis, diabetes, chronic renal disease, or malignancies.
Diagnosis is by culture and serologic testing. Amantadine can be used to
decrease the severity of influenza A disease. Vaccine is also available for high-risk populations. (Report of the Committee on Infectious Diseases, American Academy of Pediatrics, Elk Grove Village, IL., 22nd Edit., 1991, p. 274-281.)
"Virtual Pediatric Hospital", the Virtual Pediatric Hospital logo, and "A digital library of pediatric information" are all Trademarks of Donna M. D'Alessandro, M.D. and Michael P. D'Alessandro, M.D.
Virtual Pediatric Hospital is funded in whole by Donna M. D'Alessandro, M.D. and Michael P. D'Alessandro, M.D. Advertising is not accepted.
Your personal information remains confidential and is not sold, leased, or given to any third party be they reliable or not.
The information contained in Virtual Pediatric Hospital is not a substitute for the medical care and advice of your physician. There may be variations in treatment that your physician may recommend based on individual facts and circumstances.